This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
Newsramp
newsramp.com
did:plc:xlsujlrwr5xpfxgaf4pixhri
Pacylex Pharmaceuticals launches Phase 1/2 clinical trial for zelenirstat, a promising new targeted therapy for refractory Acute Myeloid Leukemia. First patient dosed at MD Anderson Cancer Center. #Cancer #Research
2025-03-26T04:50:04.699Z